February 16,2006

Senator Grassley's Statement for the Record regarding FDA's Approval Process

Please see the following two documents attached as related files:

(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression

Next Article Previous Article

Recent News

07/31/26 Working Families Tax Cuts Protect the Social Safety Net for Years to Come
07/30/26 Crapo, Wyden Applaud Committee Passage of Taxpayer Assistance and Service Act
07/30/26 Crapo Statement at Markup of Taxpayer Assistance and Service Act
07/29/26 Crapo Announces Hearing on Process Approaches for Addressing Social Security Solvency
07/28/26 Finance Committee Releases Chairman's Mark of the Taxpayer Assistance and Service Act Ahead of Markup